Register now

Calls General Rules

GENERAL RULES FOR ORAL PRESENTATIONS, POSTERS AND RISING STAR CANDIDACIES SUBMISSION

  • Abstracts should be written in English and the complete abstract must not exceed the box space (500 words). Abstracts could contain formulas, pictures or graph.
  • For each abstract a presenting author should be identified
  • All the communications concerning the abstract will be sent to the submitter who will be responsible for informing the other authors of the status of the abstract.
  • Submitting an abstract you should select the appropriate category (“Rising star”, “Oral” or “Poster).
  • Submitting an abstract you should select the appropriate topic among the ones identified for the congress.
  • Structured abstracts are mandatory stating clearly the Background/Aims, Methods, Results and Conclusions.
  • We recommend that you prepare your text in a word processing programme (e.g. Microsoft Word) and then copy-paste the final text into the online abstract submission form.
  • Abstracts must be submitted on or before the closing date in the 7th of November, 2025. The organizers reserve the right to reject any abstract for failure to comply with submission instructions mentioned on the congress website.
  • It is possible to submit more than one abstract. However, only one presenting author per abstract is permitted.
  • Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted. No proofreading will be done.
  • The presenting author must accept full responsibility for the content, submission and presentation of the abstract, and retain full copyright of their abstract and presentation. By submitting an abstract, authors give consent and authorize the organizers to publish or submit for publication their abstract, presentation, picture and biography, and to include them in any congress printed or electronic publications.
  • Submitters can go back and make changes to an abstract submitted when it is as a draft copy until the deadline. However, please note that finalized abstracts cannot be edited after approving the drafts.
  • Conflict of Interest/Disclosure: Abstracts must include an acknowledgement of any commercial funding sources. Authors should declare all commercial interests.
  • All studies must have been approved by institutional committees on ethics of experimental and human investigations.

ENCORE ABSTRACTS GUIDELINES

Encore abstracts are accepted. Please follow the ENCORE Abstracts guidelines in the submission process:

  • Authors must supply information regarding the original presentation, indicating the event where the work/abstract has been presented and the date.
  • The first author is responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).
  • Encore abstract submissions are eligible for Poster Presentation only
  • The Encore Abstract must follow the above guidelines and the General Abstract Rules above detailed.


If you have any questions regarding abstracts please contact: info@lung-health.org

SUBMISSION DEADLINE: 7th November 2025

GO TO THE SUBMISSION PAGE

GUIDELINES FOR SUBMISSION

  • Structured abstracts are mandatory stating clearly the Background/Aims, Methods, Results and Conclusions.
  • Abstracts should be written in English and the complete abstract must not exceed the box space (500 words). Abstracts can contain formulas, pictures or graphs.
  • We recommend that you prepare your text in a word processing programme (e.g. Microsoft Word) and then copy-paste the final text into the online abstract submission form.
  • It is possible to submit more than one abstract
  • A submitted abstract can have a maximum of one presenting author
  • A submitted abstract can be edited online until the given deadline (April 3rd, 2026)
  • Conflict of Interest/Disclosure: Abstracts must include an acknowledgement of any commercial funding sources. Authors should declare all commercial interests.
  • All studies must have been approved by institutional committees on Ethics of experimental and human investigations.